Molecular Characteristics and Treatment Implications of TP53 Gain‐of‐Function Mutations in Non‐Small Cell Lung Cancer

Ähnliche Einträge

• Role of TP53 Mutations and EGFR Amplification in Risk Stratification of Early‐Stage EGFR‐Mutated Non‐Small Cell Lung Cancer With Immunohistochemistry as a Surrogate Marker
  von: Meejeong Kim, et al.
  Veröffentlicht: (2025)
• Whole Exome Sequencing Study Identifies Distinct Characteristics of Transformed Small Cell Lung Cancer With EGFR Mutation Compared to De Novo Small Cell and Primary Non‐Small Cell Lung Cancers
  von: Jinjing Tan, et al.
  Veröffentlicht: (2025)
• EGFR, TP53, and CUL3 Triple Mutation in Non‐Small Cell Lung Cancer and its Potentially Poor Prognosis: A Case Report and Database Analysis
  von: Hiroto Hatano, et al.
  Veröffentlicht: (2024)
• TP53 CpG Site Mutations Predict the Survival of First‐Line Chemoimmunotherapy in Advanced Lung Adenocarcinoma
  von: Lige Wu, et al.
  Veröffentlicht: (2026)
• Impact of TP53 , KRAS , and APC Mutations on Neoadjuvant Chemotherapy Outcomes in Locally Advanced Rectal Cancer
  von: Tomohiro Takeda, et al.
  Veröffentlicht: (2025)